Gilead reports 2025 results and guides 2026 product sales to $29.6-30.0 billion

Gilead reported fourth-quarter and full-year 2025 results and set 2026 guidance. Full-year 2025 product sales were $28.9 billion, up 1%, and fourth-quarter product sales rose 5% to $7.9 billion. The 2026 outlook of $29.6 billion to $30.0 billion in product sales and non-GAAP EPS of $8.45 to $8.85 set the bar for the year, and the company said pricing and insurance changes would weigh on growth.

• Full-year 2025 product sales $28.9 billion (+1%); total revenues $29.4 billion (+2%)
• Q4 2025 product sales $7.9 billion (+5%); non-GAAP diluted EPS $1.86, GAAP $1.74
• 2026 product sales guidance $29.6 billion to $30.0 billion
• 2026 non-GAAP diluted EPS guidance $8.45 to $8.85; GAAP $6.75 to $7.15
• No total revenue growth guidance was given; product sales guidance only